Eurofins Biopharma Product Testing India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 20-11-2024
- Paid Up Capital ₹ 2.18 Cr
as on 20-11-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 75.43%
(FY 2024)
- Profit 95.56%
(FY 2024)
- Ebitda 261.87%
(FY 2024)
- Net Worth 93.49%
(FY 2024)
- Total Assets 119.28%
(FY 2024)
About Eurofins Biopharma Product Testing India
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Garg, Rajiv Malik, and Pradeep Phalke serve as directors at the Company.
- CIN/LLPIN
U74999KA2021FTC150115
- Company No.
150115
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
29 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eurofins Biopharma Product Testing India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Phalke  | Managing Director | 29-Apr-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Garg | Director | 29-Jul-2021 | Current |
| Rajiv Malik | Director | 29-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Eurofins Biopharma Product Testing India.
Eurofins Biopharma Product Testing India Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 75.43% increase. The company also saw a substantial improvement in profitability, with a 95.56% increase in profit. The company's net worth Soared by an impressive increase of 93.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurofins Biopharma Product Testing India?
In 2023, Eurofins Biopharma Product Testing India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eurofins Advinus Biopharma Services India Private LimitedActive 6 years 1 monthNeeraj Garg and Rajiv Malik are mutual person
- Eurofins Advinus Discovery Services Private LimitedActive 5 years 9 months
Neeraj Garg and Rajiv Malik are mutual person
- Eurofins Peenya Resources Private LimitedActive 19 years 8 months
Neeraj Garg and Rajiv Malik are mutual person
Eurofins Clinical Diagnostics Bangalore Private LimitedActive 9 years 10 daysNeeraj Garg is a mutual person
Adgyl Lifesciences Private LimitedActive 6 years 24 daysNeeraj Garg and Rajiv Malik are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eurofins Biopharma Product Testing India?
Eurofins Biopharma Product Testing India has a workforce of 41 employees as of Nov 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurofins Biopharma Product Testing India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Biopharma Product Testing India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
